IC261 100 mg | 99.86%
TargetMol
IC261 is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 μM and for Cdk5 is 4.5 mM.
More Information Supplier PageIC261
Search Results
IC261 25 mg | 99.86%
TargetMol
IC261 is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 μM and for Cdk5 is 4.5 mM.
More Information Supplier PageIC261
GSK2801 100 mg | 99.88%
TargetMol
GSK2801 is an effective, specific and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd: 136 nM) and BAZ2B(Kd: 257 nM) bromodomains.
More Information Supplier PageGSK2801
GSK2801 25 mg | 99.88%
TargetMol
GSK2801 is an effective, specific and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd: 136 nM) and BAZ2B(Kd: 257 nM) bromodomains.
More Information Supplier PageGSK2801
Camostat mesylate 200 mg | 99.69%
TargetMol
Camostat is a trypsin-like protease inhibitor and inhibits airway epithelial sodium channel (ENaC) function.
More Information Supplier PageCamostat mesylate
Camostat mesylate 100 mg | 99.69%
TargetMol
Camostat is a trypsin-like protease inhibitor and inhibits airway epithelial sodium channel (ENaC) function.
More Information Supplier PageCamostat mesylate
TH287 100 mg | 97.73%
TargetMol
TH287 is a potent inhibitor of MTH1 (NUDT1), less potent for MTH2, NUDT5, NUDT12, NUDT14, and NUDT16.
More Information Supplier PageTH287
SKLB4771 2 mg | Purity Not Available
TargetMol
SKLB4771
GS967 100 mg | 100.00%
TargetMol
GS967 is a potent, and selective inhibitor of cardiac late sodium current (late INa ).
More Information Supplier PageGS967
GS967 2 mg | 100.00%
TargetMol
GS967 is a potent, and selective inhibitor of cardiac late sodium current (late INa ).
More Information Supplier PageGS967